Related Experiment Video
Updated: Jan 7, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
[Triple valve replacement after recurrent infective endocarditis and previous COVID-19 infection]
D A Podchasov1, V A Ivanov1, E P Evseev1
1Petrovsky National Research Center of Surgery, Moscow, Russia.
Insights
This study details a successful triple valve replacement in a patient experiencing recurrent infective endocarditis after COVID-19. The complex cardiac surgery involved redo mitral, aortic, and tricuspid valve replacements.
Area of Science:
- Cardiology
- Cardiac Surgery
- Infectious Diseases
Background:
- Recurrent infective endocarditis poses significant challenges in cardiac surgery.
- COVID-19 infection has been linked to an increased risk of cardiovascular complications, including endocarditis.
- Previous valve surgery increases complexity in redo procedures.
Purpose of the Study:
- To report a case of successful triple valve replacement in a patient with recurrent infective endocarditis post-COVID-19.
- To highlight the feasibility of complex cardiac surgery in high-risk patients.
Main Methods:
- The patient underwent redo mitral valve replacement.
- Aortic valve replacement was performed.
- Tricuspid valve replacement was also completed.
- Surgical procedures were conducted on a patient with a high EuroSCORE II (19.24%).
Main Results:
- Successful triple valve replacement was achieved.
- The patient recovered from the complex cardiac procedure.
- The intervention addressed recurrent infective endocarditis.
Conclusions:
- Redo triple valve replacement is a viable option for select patients with recurrent infective endocarditis post-COVID-19.
- Complex cardiac surgery can be successfully performed even in high-risk individuals.
- Management of post-COVID-19 cardiac complications requires tailored surgical approaches.
Abstract:
The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis